WAY Waystar: Enterprise Value-to-Revenue Multiple

Public company logo of Waystar (WAY)

Waystar Holding Corp. enjoys immense trust from clinics within the billing sector. This daily chart of the EV/Sales multiple from the GURU.Markets service demonstrates market balance, where the value 5061.68 serves as the target level. Growth prospects are bolstered by the implementation of AI solutions, although integration challenges with legacy software and strict patient data protection regulations remain constraining factors.

waystar.com (WAY) - EV/Sales Multiple from 11/23/2025 to 11/20/2026

WAY (Waystar Holding Corp.): analytical breakdowns and indicator data

- current price and projected stock value:
- company stock capitalization data:
Fundamental company valuation:WAY Waystar
Original product of Waystar Corp

To build a high-quality portfolio, I utilize this indicator, which aggregates market capitalization and net debt, dividing them by annual revenue to determine the real value of the business excluding leverage. In the case of Waystar Holding Corp. (WAY), the enterprise value-to-revenue multiple allows for an assessment of the efficiency of cloud-based healthcare payment automation, helping to determine whether an investor is overpaying for current rates of logistics digitalization.

Direct competitors

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio CorVel Healthcare|EV/Sales Multiple Privia Medical Group|Company Value to Revenue HURN (Huron Corp)|Company Value to Revenue Certara CERT|EV/Sales Multiple OMCL (Omnicell Inc)|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)